Pro-Tumor Inflammation is one of the drivers of tumor growth, survival, and progression in certain cancers1,2

Pro-Tumor Inflammation (PTI) refers to a type of unregulated inflammation that has many possible downstream consequences, such as facilitating tumor growth and metastasis in certain cancers.1,3,4 PTI can also create a tumor microenvironment that suppresses the immune response.1,3

Find out how PTI can impact cancer


LEARN HOW

View resources about PTI and cancer


DISCOVER MORE

Explore answers to Frequently Asked Questions about PTI


VIEW FAQs

References:
1. Grivennikov SI, Greten FR, Karin M. Cell. 2010;140(6):883-899.
2. Greten FR, Grivennikov SI. Immunity. 2019;51(1):27-41.
3. Fleit HB. Part I. In: Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. 2014:300-314.
4. Lu H, Ouyang W, Huang C. Mol Cancer Res. 2006;4(4):221-233.
Contact Us Site Map

This is a global website and is intended for health care professionals. The information on this site is intended for educational purposes only and is not country-specific.

 

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2021 Novartis AG. All rights reserved.

5/21  120823

You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.

1/17 ONC-1154329